Akèy › Kansè tete negatif triple › Georgia › Athens
Etid klinik pou Kansè tete negatif triple nan Athens, GA
3 etid pou Kansè tete negatif triple ap chèche patisipan nan sit nan ak bò kote Athens (nan yon distans apeprè 30 mil). Louvri yon etid pou wè ki moun ki ka patisipe ak kijan pou kontakte ekip etid la.
Tèks ofisyèl etid la (Anglè)
Ap chèche patisipan pou yon etid? Mete l anwo paj sa a — $99 pou 30 jou →
A Study of Sacituzumab Tirumotecan (Sac-TMT, MK-2870) as Monotherapy and in Combination With Pembrolizumab (MK-3475) in Participants With Triple-Negative Breast Cancer (MK-2870-011/TroFuse-011)
Ap rekriteFaz 3
- University Cancer & Blood Center, LLC ( Site 0023), Athens
Study of Sacituzumab Govitecan-hziy and Pembrolizumab Versus Treatment of Physician's Choice in Patients With Triple Negative Breast Cancer Who Have Residual Invasive Disease After Surgery and Neoadjuvant Therapy (ASCENT-05/AFT-65 OptimICE-RD/GBG 119/NSABP B-63)
Ap rekriteFaz 3
- University Cancer & Blood Center, LLC., Athens
A Phase 1 of CTX-8371 in Patients With Advanced Malignancies
Ap rekriteFaz 1
- University Cancer & Blood Center, Athens
Etid Kansè tete negatif triple nan lòt vil
- Houston, TX42 etid
- New York City, NY31 etid
- Nashville, TN28 etid
- Los Angeles, CA27 etid
- Boston, MA26 etid
- San Antonio, TX23 etid
- St. Louis, MO21 etid
- Arlington, VA20 etid
- Atlanta, GA20 etid
- Dallas, TX18 etid
- Chicago, IL16 etid
- Columbus, OH16 etid
Lòt etid nan Athens
- Kansè Poumon ki pa ti selil17 etid
- Kansè poumon9 etid
- Kansè (tout kalite)6 etid
- Kansè kolorektal5 etid
- Kansè nan tete5 etid
- Kansè pwostat4 etid
- Kansè kolon3 etid
- Maladi poumon3 etid
- Melanom3 etid
- Skizofreni3 etid
- Twoub psikotik3 etid
- Kansè Metastatik3 etid
Sous ClinicalTrials.gov, done yo ranmase Oct 6, 2026. Chak etid gen kritè li pou li menm; ekip etid la deside ki moun ki ka patisipe.